That gap between enormous public interest and zero legal supply has created a thriving illegal market, and the Medicines and Healthcare products Regulatory Agency has spent the last nine months dismantling parts of it
An absolute risk reduction of 0.1%
The demand shows no signs of slowing down, and as a result, counterfeit GLP-1 drugs are becoming an increasingly bigger piece of the landscapeso big, in fact, that the World Health Organization (WHO) last week issued a warning to people to be wary of the fake versions
Using degraded glutathione isnt harmful, but its ineffective
Key KPI stack for revenue modeling Patient starts per quarter (new initiations) Persistence/retention (continued use under coverage and clinical response rules) Net price per treated patient (list minus rebates, chargebacks, and assistance impact) Mix by genotype and response status (responders may meet continuation criteria better) Geographic distribution and payer mix shift Specialty pharmacy fill rates and time-to-first-fill Why these KPIs matter Starts are directly tied to diagnosis volume and referral workflows
In 2011, Hassan et al